Zivo Bioscience Directors and CEO Rally in 11,709‑Share Buy, Sending Insider Confidence Skyward Amid Volatile Valuation Fluctuations
Insider buys at Zivo Bioscience signal confidence in its algal‑based platform amid volatile valuations, offering high‑risk, high‑reward potential.
3 minutes to read


